Pfizer stock has crashed 25%, reaching a 52-week low! Is this an undervalued buy opportunity with a 6% yield? Josh Brown increases his holdings, signaling an inflection point. In this Pfizer stock analysis, we delve into the reasons for the drop and assess the potential for a rebound. Stay tuned for insights on the future of PFE stock.